Panacos Pharmaceuticals, Inc. engages in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its product candidate, bevirimat, which works by a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in December 1992 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Panacos Pharmaceuticals, Inc.?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Panacos Pharmaceuticals, Inc. market cap is $100.00.
What is the 52-week high for Panacos Pharmaceuticals, Inc.?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Panacos Pharmaceuticals, Inc. 52 week high is $0.0001 as of September 12, 2025.
What is the 52-week low for Panacos Pharmaceuticals, Inc.?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Panacos Pharmaceuticals, Inc. 52 week low is $0.00 as of September 12, 2025.
What is the 50-day moving average of Panacos Pharmaceuticals, Inc.?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Panacos Pharmaceuticals, Inc. 50-day moving average is $0.00.